| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-1A adrenergic receptor binding | 4.97e-06 | 2 | 45 | 2 | GO:0031691 | |
| GeneOntologyMolecularFunction | alpha-1B adrenergic receptor binding | 1.49e-05 | 3 | 45 | 2 | GO:0031692 | |
| GeneOntologyMolecularFunction | follicle-stimulating hormone receptor binding | 1.49e-05 | 3 | 45 | 2 | GO:0031762 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.28e-04 | 507 | 45 | 7 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.28e-04 | 507 | 45 | 7 | GO:0030695 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.66e-04 | 231 | 45 | 5 | GO:0005085 | |
| GeneOntologyMolecularFunction | angiotensin receptor binding | 2.21e-04 | 10 | 45 | 2 | GO:0031701 | |
| GeneOntologyMolecularFunction | arrestin family protein binding | 3.23e-04 | 12 | 45 | 2 | GO:1990763 | |
| GeneOntologyMolecularFunction | adrenergic receptor binding | 1.33e-03 | 24 | 45 | 2 | GO:0031690 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DOCK1 IQSEC1 ROCK2 ABRA RALGDS IQSEC3 ARRB1 PLD1 F11R IQSEC2 | 1.88e-07 | 538 | 45 | 10 | GO:0007264 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 3.09e-07 | 309 | 45 | 8 | GO:1901888 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 3.17e-06 | 569 | 45 | 9 | GO:0034329 | |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 1.67e-05 | 23 | 45 | 3 | GO:0032012 | |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 1.90e-05 | 24 | 45 | 3 | GO:0032011 | |
| GeneOntologyBiologicalProcess | cell junction organization | DOCK1 IQSEC1 ROCK2 IQSEC3 FGFR1 PTPN13 THSD1 F11R IQSEC2 EPHA3 | 3.71e-05 | 974 | 45 | 10 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 7.62e-05 | 202 | 45 | 5 | GO:0051963 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 8.11e-05 | 333 | 45 | 6 | GO:0051056 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear cell cycle DNA replication | 9.71e-05 | 7 | 45 | 2 | GO:0010571 | |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 9.76e-05 | 41 | 45 | 3 | GO:0035025 | |
| GeneOntologyBiologicalProcess | synapse organization | 1.03e-04 | 685 | 45 | 8 | GO:0050808 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 1.15e-04 | 115 | 45 | 4 | GO:0150115 | |
| GeneOntologyBiologicalProcess | follicle-stimulating hormone signaling pathway | 1.29e-04 | 8 | 45 | 2 | GO:0042699 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 1.84e-04 | 387 | 45 | 6 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | DOCK1 IQSEC1 ROCK2 FGFR1 PTPN13 PLD1 F11R STXBP5 IQSEC2 EPHA3 | 1.95e-04 | 1189 | 45 | 10 | GO:0044087 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 2.06e-04 | 395 | 45 | 6 | GO:0050803 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 3.06e-04 | 803 | 45 | 8 | GO:0030036 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast growth factor production | 4.17e-04 | 14 | 45 | 2 | GO:0090270 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor production | 4.17e-04 | 14 | 45 | 2 | GO:0090269 | |
| GeneOntologyBiologicalProcess | Rho protein signal transduction | 4.45e-04 | 164 | 45 | 4 | GO:0007266 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated DNA replication | 4.80e-04 | 15 | 45 | 2 | GO:2000105 | |
| GeneOntologyBiologicalProcess | regulation of nuclear cell cycle DNA replication | 4.80e-04 | 15 | 45 | 2 | GO:0033262 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 5.30e-04 | 307 | 45 | 5 | GO:0018105 | |
| GeneOntologyBiologicalProcess | synapse assembly | 5.38e-04 | 308 | 45 | 5 | GO:0007416 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | 5.58e-04 | 667 | 45 | 7 | GO:0060627 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction organization | 5.87e-04 | 75 | 45 | 3 | GO:0150116 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 6.31e-04 | 319 | 45 | 5 | GO:0018209 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 7.12e-04 | 912 | 45 | 8 | GO:0030029 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell development | 8.62e-04 | 20 | 45 | 2 | GO:1901550 | |
| GeneOntologyBiologicalProcess | regulation of establishment of endothelial barrier | 8.62e-04 | 20 | 45 | 2 | GO:1903140 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor internalization | 9.52e-04 | 21 | 45 | 2 | GO:0002031 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-12 production | 9.52e-04 | 21 | 45 | 2 | GO:0032695 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell migration | 9.72e-04 | 202 | 45 | 4 | GO:0010634 | |
| Domain | IQSEC_PH | 9.82e-09 | 3 | 41 | 3 | IPR033742 | |
| Domain | IQ_SEC7_PH | 9.82e-09 | 3 | 41 | 3 | PF16453 | |
| Domain | - | 4.39e-06 | 15 | 41 | 3 | 1.10.1000.11 | |
| Domain | Sec7 | 4.39e-06 | 15 | 41 | 3 | PF01369 | |
| Domain | Sec7_alpha_orthog | 4.39e-06 | 15 | 41 | 3 | IPR023394 | |
| Domain | Sec7 | 5.39e-06 | 16 | 41 | 3 | SM00222 | |
| Domain | SEC7 | 5.39e-06 | 16 | 41 | 3 | PS50190 | |
| Domain | Sec7_dom | 5.39e-06 | 16 | 41 | 3 | IPR000904 | |
| Domain | Arrestin_N | 2.81e-05 | 4 | 41 | 2 | IPR014753 | |
| Domain | Arrestin | 2.81e-05 | 4 | 41 | 2 | IPR000698 | |
| Domain | - | 2.81e-05 | 4 | 41 | 2 | 2.60.40.840 | |
| Domain | Arrestin_CS | 2.81e-05 | 4 | 41 | 2 | IPR017864 | |
| Domain | ARRESTINS | 2.81e-05 | 4 | 41 | 2 | PS00295 | |
| Domain | - | 9.81e-05 | 7 | 41 | 2 | 2.60.40.640 | |
| Domain | Arrestin_C | 1.31e-04 | 8 | 41 | 2 | IPR014752 | |
| Domain | - | 1.96e-04 | 391 | 41 | 6 | 2.30.29.30 | |
| Domain | Arrestin-like_N | 2.09e-04 | 10 | 41 | 2 | IPR011021 | |
| Domain | Arrestin_C-like | 2.09e-04 | 10 | 41 | 2 | IPR011022 | |
| Domain | Arrestin_C | 2.09e-04 | 10 | 41 | 2 | PF02752 | |
| Domain | Arrestin_N | 2.09e-04 | 10 | 41 | 2 | PF00339 | |
| Domain | Arrestin_C | 2.09e-04 | 10 | 41 | 2 | SM01017 | |
| Domain | PH_dom-like | 3.11e-04 | 426 | 41 | 6 | IPR011993 | |
| Domain | PH | 3.41e-04 | 278 | 41 | 5 | SM00233 | |
| Domain | PH_DOMAIN | 3.46e-04 | 279 | 41 | 5 | PS50003 | |
| Domain | PH_domain | 3.52e-04 | 280 | 41 | 5 | IPR001849 | |
| Domain | IQ | 5.06e-04 | 71 | 41 | 3 | PF00612 | |
| Domain | IQ_motif_EF-hand-BS | 1.01e-03 | 90 | 41 | 3 | IPR000048 | |
| Domain | Kinase-like_dom | 1.10e-03 | 542 | 41 | 6 | IPR011009 | |
| Domain | IQ | 1.11e-03 | 93 | 41 | 3 | PS50096 | |
| Domain | Protein_kinase_ATP_BS | 1.38e-03 | 379 | 41 | 5 | IPR017441 | |
| Domain | Ig_E-set | 1.53e-03 | 104 | 41 | 3 | IPR014756 | |
| Domain | - | 2.67e-03 | 35 | 41 | 2 | 3.20.20.80 | |
| Domain | Pkinase_C | 2.98e-03 | 37 | 41 | 2 | IPR017892 | |
| Domain | Glyco_hydro_catalytic_dom | 3.14e-03 | 38 | 41 | 2 | IPR013781 | |
| Domain | PROTEIN_KINASE_ATP | 3.17e-03 | 459 | 41 | 5 | PS00107 | |
| Domain | Pkinase_C | 3.83e-03 | 42 | 41 | 2 | PF00433 | |
| Domain | Prot_kinase_dom | 4.15e-03 | 489 | 41 | 5 | IPR000719 | |
| Domain | PX | 4.20e-03 | 44 | 41 | 2 | SM00312 | |
| Domain | PROTEIN_KINASE_DOM | 4.30e-03 | 493 | 41 | 5 | PS50011 | |
| Domain | PX | 5.18e-03 | 49 | 41 | 2 | PF00787 | |
| Domain | PX | 5.39e-03 | 50 | 41 | 2 | PS50195 | |
| Domain | Phox | 5.82e-03 | 52 | 41 | 2 | IPR001683 | |
| Domain | Glycoside_hydrolase_SF | 6.04e-03 | 53 | 41 | 2 | IPR017853 | |
| Domain | AGC-kinase_C | 6.72e-03 | 56 | 41 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 6.72e-03 | 56 | 41 | 2 | PS51285 | |
| Domain | S_TK_X | 6.72e-03 | 56 | 41 | 2 | SM00133 | |
| Pathway | KEGG_ENDOCYTOSIS | 5.83e-06 | 181 | 36 | 6 | M1519 | |
| Pathway | PID_IL8_CXCR1_PATHWAY | 4.80e-05 | 28 | 36 | 3 | M252 | |
| Pathway | PID_ARF6_PATHWAY | 9.46e-05 | 35 | 36 | 3 | M86 | |
| Pathway | REACTOME_TGFBR3_REGULATES_TGF_BETA_SIGNALING | 1.76e-04 | 8 | 36 | 2 | M48252 | |
| Pathway | REACTOME_TGFBR3_REGULATES_TGF_BETA_SIGNALING | 1.76e-04 | 8 | 36 | 2 | MM17233 | |
| Pubmed | Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. | 2.02e-09 | 3 | 45 | 3 | 12105416 | |
| Pubmed | 1.69e-07 | 9 | 45 | 3 | 17846866 | ||
| Pubmed | Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2. | 1.64e-06 | 2 | 45 | 2 | 18703513 | |
| Pubmed | Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers. | 1.64e-06 | 2 | 45 | 2 | 17579607 | |
| Pubmed | Beta-arrestin 1 regulation of reward-motivated behaviors and glutamatergic function. | 1.64e-06 | 2 | 45 | 2 | 28973019 | |
| Pubmed | β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling. | 1.64e-06 | 2 | 45 | 2 | 26077142 | |
| Pubmed | Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. | 1.64e-06 | 2 | 45 | 2 | 17426148 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 34344831 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 21543334 | ||
| Pubmed | LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1. | 1.64e-06 | 2 | 45 | 2 | 34480046 | |
| Pubmed | ARRB2 (β-Arrestin-2) Deficiency Alters Fluid Homeostasis and Blood Pressure Regulation. | 1.64e-06 | 2 | 45 | 2 | 36215165 | |
| Pubmed | Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. | 1.64e-06 | 2 | 45 | 2 | 17618287 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 26103985 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 34450275 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 9668034 | ||
| Pubmed | Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice. | 1.64e-06 | 2 | 45 | 2 | 31622341 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 16181421 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 22886754 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 21855149 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 18519945 | ||
| Pubmed | Regulation of mitochondrial oxidative stress by β-arrestins in cultured human cardiac fibroblasts. | 1.64e-06 | 2 | 45 | 2 | 26449263 | |
| Pubmed | The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling. | 1.64e-06 | 2 | 45 | 2 | 17594911 | |
| Pubmed | Light-dependent regulation of the transcriptional activity of the mammalian gene for arrestin. | 1.64e-06 | 2 | 45 | 2 | 7932878 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 12582207 | ||
| Pubmed | Deficiency of endothelial FGFR1 signaling via upregulation of ROCK2 activity aggravated ALI/ARDS. | 1.64e-06 | 2 | 45 | 2 | 36969192 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 26927499 | ||
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 22699970 | ||
| Pubmed | beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. | 1.64e-06 | 2 | 45 | 2 | 19349687 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 21411739 | ||
| Pubmed | The Two β-Arrestins Regulate Distinct Metabolic Processes: Studies with Novel Mutant Mouse Models. | 1.64e-06 | 2 | 45 | 2 | 35008921 | |
| Pubmed | Deficiency of β-Arrestin 2 in Dendritic Cells Contributes to Autoimmune Diseases. | 1.64e-06 | 2 | 45 | 2 | 30541881 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 25134464 | ||
| Pubmed | beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. | 1.64e-06 | 2 | 45 | 2 | 11171997 | |
| Pubmed | Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins. | 1.64e-06 | 2 | 45 | 2 | 20589830 | |
| Pubmed | β-Arrestin2 mediates the initiation and progression of myeloid leukemia. | 1.64e-06 | 2 | 45 | 2 | 22773819 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 17418896 | ||
| Pubmed | β-Arrestin2 mediates progression of murine primary myelofibrosis. | 1.64e-06 | 2 | 45 | 2 | 29263312 | |
| Pubmed | β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer. | 1.64e-06 | 2 | 45 | 2 | 30787175 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 19896992 | ||
| Pubmed | Unique Roles of β-Arrestin in GPCR Trafficking Revealed by Photoinducible Dimerizers. | 1.64e-06 | 2 | 45 | 2 | 29330504 | |
| Pubmed | β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy. | 1.64e-06 | 2 | 45 | 2 | 27054338 | |
| Pubmed | Transduction of group I mGluR-mediated synaptic plasticity by β-arrestin2 signalling. | 1.64e-06 | 2 | 45 | 2 | 27886171 | |
| Pubmed | Hepatic β-arrestin 2 is essential for maintaining euglycemia. | 1.64e-06 | 2 | 45 | 2 | 28650340 | |
| Pubmed | 1.64e-06 | 2 | 45 | 2 | 8486659 | ||
| Pubmed | Scaffolding mechanism of arrestin-2 in the cRaf/MEK1/ERK signaling cascade. | 1.64e-06 | 2 | 45 | 2 | 34507982 | |
| Pubmed | β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids. | 1.64e-06 | 2 | 45 | 2 | 32027601 | |
| Pubmed | β-arrestins negatively control human adrenomedullin type 1-receptor internalization. | 1.64e-06 | 2 | 45 | 2 | 28427767 | |
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 1.93e-06 | 19 | 45 | 3 | 30674481 | |
| Pubmed | Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. | 4.91e-06 | 3 | 45 | 2 | 18787115 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 12839623 | ||
| Pubmed | Identification of receptor binding-induced conformational changes in non-visual arrestins. | 4.91e-06 | 3 | 45 | 2 | 24867953 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 26211463 | ||
| Pubmed | β-Arrestin signal complex plays a critical role in adipose differentiation. | 4.91e-06 | 3 | 45 | 2 | 23557604 | |
| Pubmed | β-Arrestin1 and 2 differentially regulate PACAP-induced PAC1 receptor signaling and trafficking. | 4.91e-06 | 3 | 45 | 2 | 29734363 | |
| Pubmed | Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling. | 4.91e-06 | 3 | 45 | 2 | 22315403 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 10549660 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 12538596 | ||
| Pubmed | Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins. | 4.91e-06 | 3 | 45 | 2 | 17272726 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 11723231 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21642958 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 27013682 | ||
| Pubmed | Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation. | 4.91e-06 | 3 | 45 | 2 | 18952848 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 20207744 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 25766502 | ||
| Pubmed | β-Arrestin2 is a critical component of the GPCR-eNOS signalosome. | 4.91e-06 | 3 | 45 | 2 | 32404425 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 20801186 | ||
| Pubmed | The transient receptor potential vanilloid 4 channel modulates uterine tone during pregnancy. | 4.91e-06 | 3 | 45 | 2 | 26702092 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 14500724 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 1458825 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21700709 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 15173580 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 28062183 | ||
| Pubmed | Quantification of beta adrenergic receptor subtypes in beta-arrestin knockout mouse airways. | 4.91e-06 | 3 | 45 | 2 | 25658948 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 25147978 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 28581517 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 24169548 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 23449980 | ||
| Pubmed | Beneficial metabolic role of β-arrestin-1 expressed by AgRP neurons. | 4.91e-06 | 3 | 45 | 2 | 32537493 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 16580177 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 9169477 | ||
| Pubmed | Direct binding of beta-arrestins to two distinct intracellular domains of the delta opioid receptor. | 4.91e-06 | 3 | 45 | 2 | 11259507 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 17525124 | ||
| Pubmed | Roles of G protein and beta-arrestin in dopamine D2 receptor-mediated ERK activation. | 4.91e-06 | 3 | 45 | 2 | 18940181 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 22025682 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 12393857 | ||
| Pubmed | Regulation of Weibel-Palade body exocytosis by alpha-synuclein in endothelial cells. | 4.91e-06 | 3 | 45 | 2 | 20448034 | |
| Pubmed | beta-Arrestins bind and decrease cell-surface abundance of the Na+/H+ exchanger NHE5 isoform. | 4.91e-06 | 3 | 45 | 2 | 15699339 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 23818521 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 16611986 | ||
| Pubmed | Host versus cell-dependent effects of β-arrestin 1 expression in prostate tumorigenesis. | 4.91e-06 | 3 | 45 | 2 | 33710266 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 12464600 | ||
| Pubmed | β-Arrestin mediates the Frank-Starling mechanism of cardiac contractility. | 4.91e-06 | 3 | 45 | 2 | 27911784 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 23302795 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 22308427 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21589858 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21757712 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21630325 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 15489220 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 17377064 | ||
| Pubmed | Prolonged photoresponses in transgenic mouse rods lacking arrestin. | 4.91e-06 | 3 | 45 | 2 | 9333241 | |
| Interaction | CRHR1 interactions | 1.35e-05 | 21 | 45 | 3 | int:CRHR1 | |
| Interaction | EIF2AK4 interactions | 2.61e-05 | 77 | 45 | 4 | int:EIF2AK4 | |
| Interaction | PARD3 interactions | 4.99e-05 | 298 | 45 | 6 | int:PARD3 | |
| Interaction | AP3B1 interactions | 5.90e-05 | 187 | 45 | 5 | int:AP3B1 | |
| Interaction | POLR1C interactions | 6.32e-05 | 311 | 45 | 6 | int:POLR1C | |
| Interaction | RALGDS interactions | 7.05e-05 | 36 | 45 | 3 | int:RALGDS | |
| Cytoband | Xq21.1 | 4.87e-04 | 33 | 45 | 2 | Xq21.1 | |
| GeneFamily | Classical arrestins | 1.29e-05 | 4 | 27 | 2 | 1312 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.62e-03 | 51 | 27 | 2 | 870 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.62e-03 | 394 | 27 | 4 | 471 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 2.82e-03 | 53 | 27 | 2 | 103 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | 7.23e-06 | 433 | 44 | 7 | M2240 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN | 1.90e-05 | 196 | 44 | 5 | M5194 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 2.57e-05 | 438 | 43 | 7 | GSM605850_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 2.68e-05 | 441 | 43 | 7 | GSM605862_500 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 188 | 45 | 5 | 4e27ada1bda88811b73376c8a6136cbfc83bfdb9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-06 | 195 | 45 | 5 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-06 | 195 | 45 | 5 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | facs-Skin-nan-18m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 149 | 45 | 4 | 23a1b95c12f2e3708dc003e13fab423e89821f11 | |
| ToppCell | facs-Skin-nan-18m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 149 | 45 | 4 | bb18a18b891af85849b9658d774053f839c9a8e1 | |
| ToppCell | facs-Skin-nan-18m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 149 | 45 | 4 | c53a3226adc8fd0eaaa842b6a96442287580cbe0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 156 | 45 | 4 | c841faa1695ff577b0774f531adf1343d05dce9e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 156 | 45 | 4 | 21baf8c6e62bb7fd1530c2c100f73c0cecee092e | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 160 | 45 | 4 | bd5fa7959bfe81011b8d798535b73ea1eee008b3 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-05 | 163 | 45 | 4 | c21114826bee1b05b411984326fef6b6e0d05316 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-05 | 163 | 45 | 4 | 5d49414432db259a19df50d7944581d00b69f537 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 164 | 45 | 4 | df9fe446c1a43100048e11c01bf009bec3414dcf | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 165 | 45 | 4 | be7e18d798e81e4b0f3080054aa222c6913e350b | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 165 | 45 | 4 | 941a5b95164eaea47c3e6376e358f94c15b98312 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 167 | 45 | 4 | 991a93e1075d562b7391f0689b2f62c1351d48d1 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 167 | 45 | 4 | 934905aeaafbc215ec8f6a7903498b0e258b9220 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 167 | 45 | 4 | f22d1471c785b30d096ec5cdc68974e850ed7de0 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 167 | 45 | 4 | 47447bcf184b1ad24ef17e135199fe7cd1d73c02 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 168 | 45 | 4 | a4eebc78babb9b5ef33065b0642793820195a613 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-05 | 170 | 45 | 4 | f524b73d65941ebef7671c46df4362a3f15d24fc | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-05 | 171 | 45 | 4 | 26755e43d94e934106fc19ab929e4d34c17d6cba | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-05 | 172 | 45 | 4 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-05 | 172 | 45 | 4 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | facs-Heart-RA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 173 | 45 | 4 | 5058cb5e3f2d57dbe947e1b113eb2bef7bf6dd7d | |
| ToppCell | facs-Heart-RA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 173 | 45 | 4 | 4fa5f502fa3ff8f888e279f68a0dafd91b37f26f | |
| ToppCell | facs-Heart-RA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 173 | 45 | 4 | ea406b47ff3ead992bc06f6b1707c76eee574782 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 176 | 45 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 176 | 45 | 4 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.11e-05 | 178 | 45 | 4 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | CV-Severe-4|Severe / Virus stimulation, Condition and Cluster | 3.25e-05 | 180 | 45 | 4 | cf84a01e6a33e5d27ad7be1d9069a0370b5116d1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 181 | 45 | 4 | 8657d35cd3dff6c89d0fde67d7e7e81e1d6c8884 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-05 | 181 | 45 | 4 | 7b6454972041a9b4e4ff2f313e8432d9040b8544 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 182 | 45 | 4 | 1fb9bdf2e9f0a9c230f109b471672f9c31e27c82 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 182 | 45 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-05 | 184 | 45 | 4 | ba260f8a2e6e510141a6b9c458eb0040acff0352 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 185 | 45 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-05 | 186 | 45 | 4 | 69b107ad88b07e9aeef09d4e4dac99b0cb6b467e | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 186 | 45 | 4 | ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.77e-05 | 187 | 45 | 4 | 8e1d6d25db5b5c91a651bb2d66edfcf073a31704 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 188 | 45 | 4 | 4dc89c7843ebd078e3414e835c56f11fa27f0c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 188 | 45 | 4 | d577b3c2a844e3062c7ca9e9ebc1722d0ac95caa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 188 | 45 | 4 | 1e788b60dd643bf220d8dfafa82d85fd083cbc71 | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.93e-05 | 189 | 45 | 4 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 191 | 45 | 4 | 94c7da03e5264f4d73bb507ce339a935d90279a0 | |
| ToppCell | facs-Brain_Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 191 | 45 | 4 | bf1135b382a3bf8cddc19538bc38361ef1fc2de1 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 191 | 45 | 4 | 1e668d67bc254ea15518e2c7a029a61087609b7a | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.18e-05 | 192 | 45 | 4 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.18e-05 | 192 | 45 | 4 | 62eac1b8aed4fb924946b58c0237313f697a0136 | |
| ToppCell | Monocytes-Inflammatory_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.18e-05 | 192 | 45 | 4 | 4be5c2c946337cd3e710137726358adca563f146 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Granulocytic-Neutrophil|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-05 | 192 | 45 | 4 | e2fa1ba26d28953f0d35d95764b5dbe0b93a1191 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Granulocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-05 | 192 | 45 | 4 | 161f4626571b1bce5758fad1fe5ce41a4621771d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.26e-05 | 193 | 45 | 4 | cb0fb21510124883e716780bea46575620c366b8 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.26e-05 | 193 | 45 | 4 | 0c207879f994c227dcd1322faa69ec9e3749cdaa | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Monocytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.26e-05 | 193 | 45 | 4 | ddbd8944661ac3b0b5fe63471bdc24ba05598017 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.26e-05 | 193 | 45 | 4 | 0fbbfcc803edc3cd96b35467ad5cc573af07fd67 | |
| ToppCell | medial-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.35e-05 | 194 | 45 | 4 | 202e5070728191c46161fa7d931f00be1c7559d4 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.35e-05 | 194 | 45 | 4 | 002cd317732fc6b0d9a72fb46199f71db5a638a7 | |
| ToppCell | (2)_Mono_macro|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.35e-05 | 194 | 45 | 4 | 7c05525614ee8cdfcbf22cce9146a8e73af7d14e | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.35e-05 | 194 | 45 | 4 | ac203d388a3a3884e316dec0dcbd408e43c6ef6c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.44e-05 | 195 | 45 | 4 | f8908657db50f1c58904dd6fee4fc23f5ae3eed6 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.44e-05 | 195 | 45 | 4 | 01da7115e38c280fb0baff2032b62bdb609bad5e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.44e-05 | 195 | 45 | 4 | c14d730dd5c94247bc09711eaa5a53bd5a5957be | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.44e-05 | 195 | 45 | 4 | 935461e849ca4d17627341b3ae5124d497793a91 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.44e-05 | 195 | 45 | 4 | aa3914e277918299dc7d2995c0c72288462ad43d | |
| ToppCell | Monocytes-NUPR1+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.44e-05 | 195 | 45 | 4 | 5e12201ce7ba912e7faa123ca200e609252ba288 | |
| ToppCell | distal-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.44e-05 | 195 | 45 | 4 | 34bed73e4dae34b0f1076b7ff9dc7ea2096c1796 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-05 | 195 | 45 | 4 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.53e-05 | 196 | 45 | 4 | 51fc8bb9a806f8fbf78d5d80d535f1068a9770c2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 196 | 45 | 4 | 291c59b609985167c98a40d4e2caeea2fad74941 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 4.53e-05 | 196 | 45 | 4 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.53e-05 | 196 | 45 | 4 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.53e-05 | 196 | 45 | 4 | f811958823380069077754283e36106d80147494 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.53e-05 | 196 | 45 | 4 | 894f9943404cf252dbdf9e5769d9238f982ba8b8 | |
| ToppCell | Monocytes-IL1B+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.53e-05 | 196 | 45 | 4 | 7bc0735d324ac5a1661434cda4116ddd58296730 | |
| ToppCell | remission-Non-classical_Monocyte|remission / disease stage, cell group and cell class | 4.53e-05 | 196 | 45 | 4 | 049d995986c20ce066bd64fcc2d2f1c2f8899883 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.53e-05 | 196 | 45 | 4 | aa53ae1e5d08d31cfd81b7fae46c2b5d21d4f9b2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 196 | 45 | 4 | 63b841457d12fb9dd25630e3c348d3ef53463f86 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 197 | 45 | 4 | 1c0024049db2d2c817a7f503de235b9630b24e33 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 197 | 45 | 4 | 759f26753f76af3ae8d8527c4d221206245a3d45 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 197 | 45 | 4 | 555ea43eccc3eb22be230c27e13d8b3b64c2a61f | |
| ToppCell | wk_20-22-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.62e-05 | 197 | 45 | 4 | e862561f61a1ae1ec858b34f8d9c9a7dc8894104 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 197 | 45 | 4 | 2efb5acd56b96e5afd8d72b927f1d53cc443766f | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.62e-05 | 197 | 45 | 4 | eecb693367510da20a6b1e9355e68785a1e3b85c | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 197 | 45 | 4 | e698a0bbb20bd4868ff4348f2ac9f609942b55fa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.62e-05 | 197 | 45 | 4 | 4d3670456655248250d156f92de01df4aa481733 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.71e-05 | 198 | 45 | 4 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-05 | 198 | 45 | 4 | d681aff379720261d85f9c1c6030932c5046960e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-05 | 198 | 45 | 4 | 8fe5e6b563bee2179b0f17d6591870d7dd76e891 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-05 | 198 | 45 | 4 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | remission-Non-classical_Monocyte|World / disease stage, cell group and cell class | 4.71e-05 | 198 | 45 | 4 | 1c170655070acca00520b7cf9c510a04c0a90a8f | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 4.71e-05 | 198 | 45 | 4 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 4.71e-05 | 198 | 45 | 4 | 187a04d498f0b355cb11c81172721698818082d6 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-iMON-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.71e-05 | 198 | 45 | 4 | a6aa113f0af4d25c032f440c3134fe4d88ca5055 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-05 | 198 | 45 | 4 | c00dbe61dc25602f19bd42a760646680002961ca | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.71e-05 | 198 | 45 | 4 | a0ceed8689d42be6b9cde89d6c182d10b3fb14fc | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.71e-05 | 198 | 45 | 4 | 6d547122b8c4ddbdd0d3dae3bce4a125740d5457 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.71e-05 | 198 | 45 | 4 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-05 | 198 | 45 | 4 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 4.71e-05 | 198 | 45 | 4 | 065c8a9655d19f93dfdb453c78bbfe7d857caf3e | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.80e-05 | 199 | 45 | 4 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 3.58e-05 | 190 | 45 | 5 | 3379_DN | |
| Drug | 2,2,2-trifluoroethanethiol | 3.81e-05 | 5 | 45 | 2 | CID004133924 | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.95e-05 | 194 | 45 | 5 | 5696_DN | |
| Drug | Megestrol acetate [595-33-5]; Up 200; 10.4uM; HL60; HT_HG-U133A | 4.05e-05 | 195 | 45 | 5 | 3091_UP | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 5679_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 1687_UP | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 1692_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A | 4.25e-05 | 197 | 45 | 5 | 3004_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.25e-05 | 197 | 45 | 5 | 3750_DN | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; HL60; HT_HG-U133A | 4.36e-05 | 198 | 45 | 5 | 3104_UP | |
| Drug | Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 4.36e-05 | 198 | 45 | 5 | 4594_UP | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | 4.46e-05 | 199 | 45 | 5 | 7287_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 4.57e-05 | 200 | 45 | 5 | 2190_UP | |
| Drug | Flavone | 4.91e-05 | 102 | 45 | 4 | CID000010680 | |
| Disease | thrombin generation potential measurement, thrombomodulin measurement | 5.51e-05 | 8 | 42 | 2 | EFO_0005538, EFO_0007774 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.98e-05 | 53 | 42 | 3 | C1961099 | |
| Disease | Mental Retardation, X-Linked | 7.84e-04 | 29 | 42 | 2 | C1136249 | |
| Disease | tea consumption measurement | 8.27e-04 | 129 | 42 | 3 | EFO_0010091 | |
| Disease | Large cell carcinoma of lung | 9.55e-04 | 32 | 42 | 2 | C0345958 | |
| Disease | Squamous cell carcinoma of lung | 9.55e-04 | 32 | 42 | 2 | C0149782 | |
| Disease | triglyceride measurement, response to diuretic | 1.08e-03 | 34 | 42 | 2 | EFO_0004530, GO_0036270 | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 1.21e-03 | 36 | 42 | 2 | DOID:3907 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGKIYSIKEFKEVEK | 176 | P0C875 | |
| EKKKKITVFKEISYT | 356 | Q9UNQ0 | |
| LNKGSVKTKFYVLKV | 441 | Q6P1M9 | |
| GIIVSYKVKVKLVVS | 316 | P49407 | |
| TKTVKKIKVSVRQYA | 226 | P32121 | |
| FKVVERETKTKAYSK | 91 | O75175 | |
| KVIVKTMKTYVEKVA | 381 | Q15397 | |
| VITLAIYGTRKFKKK | 671 | Q2M385 | |
| QYKKVTASKVFLAIK | 206 | P0C860 | |
| VVTKIFQKKKNSVTY | 786 | Q6DN90 | |
| VTKIFQKKKILVTYS | 1006 | Q5JU85 | |
| KFAYGKVTLEKLKTV | 371 | P16278 | |
| SVSKITKSGVKVSVY | 256 | Q9NZ08 | |
| FGYQKTKKVEKSKIF | 641 | Q9NVP1 | |
| VTYVTKVEKSIVGMK | 846 | Q9UPP2 | |
| SKTTAKVTKELYVKL | 576 | P46100 | |
| KLKVVITSKSGEILY | 141 | Q04446 | |
| KYLAKTGETFVKLVV | 1161 | Q14185 | |
| SLKSKGVYFIKTKSE | 71 | Q9UFH2 | |
| VGSVIVYKMKSGTKK | 391 | P11362 | |
| KEISVAIKTLKVGYT | 646 | P29320 | |
| YDFVLKKRTFTKGVK | 876 | Q12967 | |
| KKVYFAEKVTSLGKD | 131 | P52943 | |
| EKKKRFTVYKVLVSV | 26 | Q96BR1 | |
| KVYKKKITLVNTTYT | 531 | Q9C0B2 | |
| KVKKTTQVKDYSFVT | 1481 | Q12923 | |
| VYGVKTKQIRKSVIK | 301 | Q8NH56 | |
| LKDVFSKYGKTLSVK | 206 | P0CB38 | |
| LVSARKGSKFKKITY | 126 | Q6UXV4 | |
| FDRTKKGTSSKKVIY | 266 | Q9Y624 | |
| KIILAVKSKGKFYLV | 286 | Q96EX2 | |
| KSGKTTVAKKITSEY | 1421 | Q5TCS8 | |
| EFKIKVGKKETETKY | 281 | Q13393 | |
| TGTKTGKKTLQVVVY | 1591 | Q5T5P2 | |
| VGKCKTIVSKYETKY | 286 | Q10587 | |
| VKKVKKKLTYQFSGE | 241 | P17947 | |
| QVLYKLKTSKVFEKS | 471 | Q5T5C0 | |
| KKEVSKTVVSKTYER | 106 | Q8N0Z2 | |
| TSIVEKGKTKYVIFK | 186 | Q9HAY6 | |
| KGKTKYVIFKIPATV | 191 | Q9HAY6 | |
| LVKEKSKIYEKTFTL | 106 | Q8N184 | |
| INQSKKTVFVLTKKY | 936 | Q9NR97 | |
| KYKISTKTNKVYDIT | 116 | Q8IXW5 | |
| KKKGLTETTKVYHVS | 541 | Q9NS62 | |
| VKKYVIVSSKKILFY | 1171 | O75116 | |
| VKVATSKKYKGTVAI | 26 | Q9BXA6 | |
| SKKYKGTVAIKVVDR | 31 | Q9BXA6 | |
| KIYEEKKKKTTTIAV | 286 | Q00341 |